BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36480849)

  • 1. [Retrospective analysis and a cross-sectional questionnaire survey of lung cancer concomitant with interstitial lung disease].
    Liu XN; Li J; Chen RX; Shao C; Huang H; Xu X; Zhang MZ; Wang ZJ; Xu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1192-1198. PubMed ID: 36480849
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical spectrum of Chinese hospitalized lung cancer patients with concomitant interstitial lung disease: before and after the new era of LC treatment.
    Chen R; Shao C; Liu X; Huang H; Pan B; Xu K; Zhu R; Li M; Zhao Y; Chen K; Wang M; Xu Z
    Clin Exp Med; 2023 Oct; 23(6):2321-2330. PubMed ID: 36715832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
    Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
    Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
    Kenmotsu H; Naito T; Kimura M; Ono A; Shukuya T; Nakamura Y; Tsuya A; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
    J Thorac Oncol; 2011 Jul; 6(7):1242-6. PubMed ID: 21623239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the clinical features of lung cancer in patients with connective tissue diseases.
    Saijo A; Hanibuchi M; Goto H; Toyoda Y; Tezuka T; Nishioka Y
    Respir Investig; 2017 Mar; 55(2):153-160. PubMed ID: 28274531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
    Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
    Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
    Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
    Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer.
    Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Anticancer Res; 2019 Oct; 39(10):5725-5731. PubMed ID: 31570474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JOURNAL CLUB: Evidence of Interstitial Lung Disease on Low-Dose Chest CT Images: Prevalence, Patterns, and Progression.
    Salvatore M; Henschke CI; Yip R; Jacobi A; Eber C; Padilla M; Knoll A; Yankelevitz D
    AJR Am J Roentgenol; 2016 Mar; 206(3):487-94. PubMed ID: 26700157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of the appropriate treatment for the combination of interstitial lung disease and lung cancer: A retrospective observational study.
    Karapinar K; Yurt S; Toptaş M; Bahadir A; Erdoğu V; Akçil AM; Onur ST
    Medicine (Baltimore); 2024 Feb; 103(6):e37186. PubMed ID: 38335429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.
    Kenmotsu H; Yoh K; Mori K; Ono A; Baba T; Fujiwara Y; Yamaguchi O; Ko R; Okamoto H; Yamamoto N; Ninomiya T; Ogura T; Kato T
    Cancer Sci; 2019 Dec; 110(12):3738-3745. PubMed ID: 31608537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer development in patients with connective tissue disease-related interstitial lung disease: A retrospective observational study.
    Enomoto Y; Inui N; Yoshimura K; Nishimoto K; Mori K; Kono M; Fujisawa T; Enomoto N; Nakamura Y; Iwashita T; Suda T
    Medicine (Baltimore); 2016 Dec; 95(50):e5716. PubMed ID: 27977621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.
    Fujimoto D; Tomii K; Otoshi T; Kawamura T; Tamai K; Takeshita J; Tanaka K; Matsumoto T; Monden K; Nagata K; Otsuka K; Nakagawa A; Hata A; Tachikawa R; Otsuka K; Hamakawa H; Katakami N; Takahashi Y; Imai Y
    Lung Cancer; 2013 May; 80(2):159-64. PubMed ID: 23419507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives.
    Hanibuchi M; Ogino H; Sato S; Nishioka Y
    J Med Invest; 2024; 71(1.2):9-22. PubMed ID: 38735730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
    Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
    Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
    Kakiuchi S; Hanibuchi M; Tezuka T; Saijo A; Otsuka K; Sakaguchi S; Toyoda Y; Goto H; Kawano H; Azuma M; Ogushi F; Nishioka Y
    Respir Investig; 2017 Mar; 55(2):145-152. PubMed ID: 28274530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.